Comparing Patients Responding Well to Infliximab-Originator and Patients Switched to an Infliximab-Biosimilar. A Preliminary Analysis from the Rhumadata Clinical Database and Registry

Choquette Denis; Bessette Louis; Haraoui Boulos; Massicotte Frederic; Pelletier Jean-Pierre; Raynauld Jean-Pierre; Remillard Marie-Anais; Sauvageau Diane; Turcotte Angele; Villeneuve Edith; Coupal Louis

首页> 外文期刊>The Journal of rheumatology >Comparing Patients Responding Well to Infliximab-Originator and Patients Switched to an Infliximab-Biosimilar. A Preliminary Analysis from the Rhumadata Clinical Database and Registry

【24h】

Comparing Patients Responding Well to Infliximab-Originator and Patients Switched to an Infliximab-Biosimilar. A Preliminary Analysis from the Rhumadata Clinical Database and Registry

机译：将患者与富集昔单抗的患者进行比较，患者切换到英夫利昔单抗。 rhumadata临床数据库和注册表的初步分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of rheumatology》 |2019年第7期|共2页
作者
Choquette Denis; Bessette Louis; Haraoui Boulos; Massicotte Frederic; Pelletier Jean-Pierre; Raynauld Jean-Pierre; Remillard Marie-Anais; Sauvageau Diane; Turcotte Angele; Villeneuve Edith; Coupal Louis;
展开▼
作者单位

Inst Rhumatol Montreal Montreal PQ Canada;

Laval Univ Quebec City PQ Canada;

Inst Rhumatol Montreal Montreal PQ Canada;

Inst Rhumatol Montreal Montreal PQ Canada;

Inst Rhumatol Montreal Montreal PQ Canada;

Inst Rhumatol Montreal Montreal PQ Canada;

Inst Rhumatol Montreal Montreal PQ Canada;

Inst Rhumatol Montreal Montreal PQ Canada;

Ctr Osteoporose &

Rhumatol Quebec Quebec City PQ Canada;

Inst Rhumatol Montreal Montreal PQ Canada;

Inst Rhumatol Montreal Montreal PQ Canada;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类免疫性疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Comparing Patients Responding Well to Infliximab-Originator and Patients Switched to an Infliximab-Biosimilar. A Preliminary Analysis from the Rhumadata Clinical Database and Registry [J] . Choquette Denis, Bessette Louis, Haraoui Boulos, The Journal of rheumatology . 2019,第7期

机译：将患者与富集昔单抗的患者进行比较，患者切换到英夫利昔单抗。 rhumadata临床数据库和注册表的初步分析
2. Use of Rituximab Compared to Anti-TNF Agents as Second and Third Line Therapy in Patients with Rheumatoid Arthritis. A 6 Year Follow-Up Report from the Rhumadata Clinical Database and Registry [J] . Choquette Denis, Bessette Louis, Brown Jacques, The Journal of rheumatology . 2016,第6期

机译：利托妥昔单抗与抗TNF药剂相比，作为类风湿性关节炎患者的第二和第三线治疗。 Rhumadata临床数据库和注册表中的6年后续报告
3. Use of Rituximab Compared to Anti-TNF Agents as Second and Third Line Therapy in Patients with Rheumatoid Arthritis: A Report from the RHUMADATA (R) Clinical Database and Registry [J] . Choquette Denis, Bessette Louis, Fortin Isabelle, The Journal of rheumatology . 2015,第7期

机译：类风湿关节炎患者二线和三线治疗与利妥昔单抗相比抗TNF药物的使用：来自RHUMADATA（R）临床数据库和注册处的报告
4. Development of Patient State Model to Overview Clinical Registry Database [C] . Masamichi Ishii, Kengo Miyo, Takehiro Sugiyama, MEDINFO . 2019

机译：患者状态模型的开发概述临床登记数据库
5. A Cost-utility Analysis of Biosimilar Infliximab Compared to Reference Infliximab in Adult Switch Patients with Crohn's Disease: A Canadian Analysis [D] . Hughes, Avery. 2018

机译：生物纤维生素infiximab的成本实用性分析与成人交换患者参考incriximab患者克罗恩病患者：加拿大分析
6. Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry [O] . Denis Choquette, Louis Bessette, Evo Alemao, 2019

机译：在类风湿性关节炎治疗中用作第一或第二种生物DMARD的abatacept和TNF抑制剂的持久性：从Rhumadata®临床数据库和注册表中获得9年的经验
7. The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels:a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144) [O] . Nolen Willem A., Weisler Richard H. 2013

机译：锂在双相情感障碍维持治疗中的作用与锂血浆水平的关联：一项对喹硫平有反应的患者改用锂或安慰剂的双盲研究的事后分析（试验144）
8. CAPD (Continuous Ambulatory Peritoneal Dialysis) Patient Registry: Report on Patient Data in Pilot Study for the CAPD Patient Registry - January 1, 1981 to March 31, 1981 [R] . Pyle, W. K. , Hiatt, M. P. , Grant, J. E. 1981

机译：CapD（持续性非卧床腹膜透析）患者登记处：CapD患者登记处试点研究中的患者数据报告 - 1981年1月1日至1981年3月31日

Comparing Patients Responding Well to Infliximab-Originator and Patients Switched to an Infliximab-Biosimilar. A Preliminary Analysis from the Rhumadata Clinical Database and Registry

著录项

相似文献

相关主题

期刊订阅